Literature DB >> 3773834

Intrathecal baclofen for severe spasticity.

G J Hankey, E G Stewart-Wynne, D Perlman.   

Abstract

The intrathecal administration of baclofen by way of an implanted subcutaneous drug delivery system is described in a patient with a severe spastic paraparesis due to multiple sclerosis. Intrathecally-administered baclofen is proposed as another therapeutic dimension and adjunct to physical therapy in the management of patients with severe spasticity that is unresponsive to antispasticity agents administered by mouth.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3773834     DOI: 10.5694/j.1326-5377.1986.tb113877.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  1 in total

1.  Treatment of severe tetanus by intrathecal infusion of baclofen.

Authors:  A Pellanda; D Caldiroli; G M Vaghi; S Bonelli
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.